ANALYSIS OF COMPLICATIONS IN PATIENTS WITH VARIOUS TACTICS OF ENDOVASCULAR TREATMENT, DEPENDING ON THE REGIMEN OF ANTIPLATELET THERAPY

Abstract

Aim. Of the study was to study the complications in patients with thrombosis of a heart attack-responsible artery of various sizes three six and twelve months after the endovascular treatment.Materials and methods. The study included 270 patients (216 men, 54 women) with acute coronary syndrome. Depending on the treatment, patients are divided into three groups. In group 1 (n = 110) - with emergency percutaneous intervention supplemented with thrombospiration for a responsible heart attack without thrombolytic therapy; Group 2 (n = 70) - with emergency emergency transdermal intervention supplemented with thrombospiration on a heart attack artery with prehospital thrombolytic therapy; group 3 (n = 90) - with emergency percutaneous intervention on a heart attack artery, without thrombolytic therapy and without thrombaspiration .Results. Based on the results of the risk analysis of the Complications target, we can conclude that the three key statistically significant factors for the development of the Complications risk are LVEF,% <0.5, Group (Without TA (PCI)) and Type interventions (Without TA (PCI)) ”with absolute risk levels of “ Complications ”of more than 30.0%. The presence of one of three key factors increases the risk of Complications by more than 7 times